Publications by authors named "Francesca Daniel"

Claim this Profile
T
The role of sodium zirconium cyclosilicate drug utilization in managing hyperkalemia: impact on healthcare resource utilization and on maintenance of renin-angiotensin-aldosterone system inhibitor therapy in Italian clinical practice.
Marco Gnesi, Francesca Daniel, Valentina Mongelli, Andrea Merlo, Nicola Cosentino

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab.
Chiara Pirrone, Umberto Malapelle, Francesco Pepe, Federica Lo Prinzi, Federico Nichetti, Daniele Lavacchi, Francesca Daniel

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
Valentina Fanotto, Daniele Rossini, Mariaelena Casagrande, Francesca Bergamo, Andrea Spagnoletti, Daniele Santini, Francesca Daniel

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Impact of Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable -Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy.
Roberto Moretto, Marco Maria Germani, Javier Ros, Francesca Daniel, Filippo Ghelardi, Daniele Rossini

JCO Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials.
Alessandra Boccaccino, Daniele Rossini, Alessandra Raimondi, Martina Carullo, Sara Lonardi, Daniele Santini, Francesca Daniel

Eur J Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study.
Federica Marmorino, Lorenzo Faggioni, Daniele Rossini, Michela Gabelloni, Antonio Goddi, Francesca Daniel

Future Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer.
Letizia Procaccio, Francesca Bergamo, Maura Gatti, Benedetta Chiusole, Giuseppina Tierno, Francesca Daniel

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients.
Antonella Galiano, Stefania Schiavon, Mariateresa Nardi, Irene Guglieri, Ardi Pambuku, Francesca Daniel

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO.
Emanuela Dell'Aquila, Daniele Rossini, Alessandro Galletti, Marco Stellato, Alessandra Boccaccino, Francesca Daniel, Daniele Santini

Clin Colorectal Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
Andrea Sartore-Bianchi, Filippo Pietrantonio, Sara Lonardi, Benedetta Mussolin, Francesco Rua, Francesca Daniel, Daniele Regge

Nat Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies.
Carlotta Antoniotti, Marco M Germani, Daniele Rossini, Sara Lonardi, Filippo Pietrantonio, Daniele Santini, Francesca Daniel

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target.
Selma Ahcene Djaballah, Francesca Daniel, Anna Milani, Gianmarco Ricagno, Sara Lonardi

Am Soc Clin Oncol Educ Book· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature.
Pasquale Lombardi, Daniele Rossini, Veronica Crespi, Marco Maria Germani, Francesca Bergamo, Daniele Santini, Francesca Daniel

Cancer Treat Rev· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study.
Letizia Procaccio, Francesca Bergamo, Francesca Daniel, Cosimo Rasola, Giada Munari

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.
Giovanni Fucà, Francesca Corti, Margherita Ambrosini, Rossana Intini, Massimiliano Salati, Francesca Daniel

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramucirumab: the long and winding road toward being an option for mCRC treatment.
Celine Debeuckelaere, Sabina Murgioni, Sara Lonardi, Noemi Girardi, Giulia Alberti, Francesca Daniel

Expert Opin Biol Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis